
The Pfizer COVID vaccine significantly reduced U.S. children’s risk of severe illness and hospitalization during the recent Omicron surge, according to a new study. But researchers noted that only 27% of 5- to 11-year-olds in the United States and just 57% of 12- to 17-year-olds had received two vaccine doses as of March 16, and… read on > read on >